Kanoria Chemicals posts FY26 profit of ₹11,319 crore; revenue up 30%

scanx
Reviewed by
Suketu GScanX News Team
Key Highlights
  • Consolidated net profit turned positive to ₹11,319 crore in FY26 from a loss of ₹10,815 crore in FY25
  • Operating revenue grew 30% to ₹98,143 crore driven by improved volumes and efficiencies
  • EBITDA surged 90% to ₹9,379 crore with margins expanding to 9.3%
  • Promoters infusing ₹49.5 crore via NCRPS to support future growth plans
powered bylight_fuzz_icon
49896550

*this image is generated using AI for illustrative purposes only.

Kanoria Chemicals & Industries concluded its 66th Annual General Meeting (AGM) on September 2, 2026. The meeting was held via Video Conferencing/Other Audio-Visual Means in compliance with SEBI and MCA regulations.

The company shared its AGM presentation with shareholders, revealing a significant turnaround in financial performance for FY26. Consolidated operating revenue rose 30% to ₹98,143 crore from ₹75,431 crore in FY25. Net profit swung to ₹11,319 crore from a loss of ₹10,815 crore the previous year.

Financial Performance

The improved results were driven by higher operating efficiencies and volumes. Standalone operating revenue increased by 29% to ₹87,534 crore, while EBITDA grew 52% to ₹8,158 crore. EBITDA margins expanded to 9.3% from 7.9% in FY25.

Metric FY26 (₹ crore) FY25 (₹ crore) Change
Operating Revenue 98,143 75,431 +30%
EBITDA 9,379 4,936 +90%
Net Profit 11,319 -10,815 Turnaround

The standalone entity reported an exceptional item representing a non-cash impairment loss of investments in APAG Holding AG, its erstwhile subsidiary. Additionally, the company benefited from a negative tax impact of ₹214.3 crore due to the reversal of Deferred Tax under the 'New Tax Regime'.

Subsidiary and Discontinued Operations

APAG Holding AG ceased to be a subsidiary during the year, with its results shown under Discontinued Operations. This segment included a gain on loss of control of ₹976.5 crore. Kanoria Africa Textiles PLC delivered stronger performance with operating revenue up 40% to ₹1,060.8 crore and EBITDA increasing over 14 times to ₹192.5 crore.

Meeting Proceedings

Rajya Vardhan Kanoria, Chairman, presided over the meeting. He introduced the Board of Directors and key management personnel participating via video conference. The directors present included:

  • Meeta Makhan, Non-executive Independent Director and Chairperson of the Audit Committee
  • Sidharth Kumar Birla, Non-executive Independent Director and Chairman of the Nomination & Remuneration Committee
  • Suhana Murshed, Non-executive Independent Director and Chairperson of the Stakeholders' Relationship Committee
  • Madhuvanti Kanoria, Non-executive Non-Independent Director and Chairperson of the Corporate Social Responsibility Committee
  • Saumya Vardhan Kanoria, Whole-Time Director
  • Sumanta Chaudhuri, Non-executive Independent Director
  • Hemant Kumar Khaitan, Non-executive and Non-Independent Director

Nirmal Kumar Nolkha, Group Chief Financial Officer, and Pratibha Jaiswal, Company Secretary, also attended. The statutory auditors, Singhi & Co., secretarial auditors, MR & Associates, and scrutinizer Amit Choraria were present to oversee the process.

Resolutions Approved

The AGM transacted both ordinary and special business items. Remote e-voting was available from August 30, 2026, at 9:00 am to September 1, 2026, at 5:00 pm. Members participating in the VC could also vote during the meeting.

The following resolutions were passed:

Resolution Type Item Description Status
Ordinary Adoption of Audited Financial Statements for FY26 Passed
Ordinary Re-appointment of Hemant Kumar Khaitan as Director Passed
Special Re-appointment of Suhana Murshed as Independent Director for 5 years Passed
Special Ratification of Cost Auditors' remuneration for FY27 Passed

Pratibha Jaiswal confirmed that the requisite quorum was present and the meeting was conducted in order. The Chairman noted that the reports of the Statutory Auditors and Secretarial Auditor for the year ended March 31, 2026, contained no qualifications or adverse remarks.

Future Outlook

The company outlined its 'Vision 2030' roadmap aimed at sustainable growth. Key initiatives include diversification into specialty chemicals such as Triacetin and Penta Derivatives, which are expected to be commissioned shortly. The firm is actively pursuing capacity addition in Formaldehyde and Resin while continuing cost reduction programs.

Promoters are contributing ₹49.5 crore through a 7% Non-Convertible Redeemable Preference Shares (NCRPS) issue. However, the company highlighted threats from geopolitical situations and high tariffs as potential headwinds.

Historical Stock Returns for Kanoria Chemicals & Industries

1 Day5 Days1 Month6 Months1 Year5 Years
-0.92%-2.64%+8.69%+125.81%+84.51%+1.58%

How will the upcoming commissioning of specialty chemical units for Triacetin and Penta Derivatives impact Kanoria's EBITDA margins in FY27 compared to the current 9.3%?

What specific mitigation strategies has management outlined to counter the projected headwinds from geopolitical instability and high tariffs on its export-oriented segments?

With APAG Holding AG now classified under discontinued operations, how will the absence of this subsidiary's volatility affect the company's future revenue growth trajectory?

Kanoria Chemicals & Industries
View Company Insights
View All News
like17
dislike

Kanoria Chemicals & Industries Q1 Results: Board approves unaudited financials

scanx
Reviewed by
Shriram SScanX News Team
Key Highlights

Kanoria Chemicals & Industries Limited announced its Q1FY26 unaudited results on August 12, 2026. The Board approved the standalone and consolidated figures on August 11. The results were published in Financial Express and Ekdin, complying with SEBI LODR Regulations 30 and 47. Detailed financial metrics are available via the company website and stock exchanges.

powered bylight_fuzz_icon
48083141

*this image is generated using AI for illustrative purposes only.

Kanoria Chemicals & Industries declared its unaudited financial results for the first quarter of FY26 on August 12, 2026. The disclosure covers both standalone and consolidated financial statements for the quarter ended June 30, 2026. This filing ensures transparency for investors and complies with regulatory mandates regarding timely financial reporting.

The Board of Directors approved the financial results during a meeting held on August 11, 2026, in New Delhi. R.V. Kanoria, Chairman & Managing Director, signed off on the statement. The company subsequently disseminated the results through multiple channels to ensure wide accessibility for stakeholders.

Regulatory Compliance and Dissemination

The company complied with Regulation 30 and Regulation 47 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. These regulations mandate the prompt disclosure of financial results to stock exchanges and the public.

Kanoria Chemicals published the extract of the unaudited financial results in two newspapers: Financial Express (English) and Ekdin (Bengali). The publication date was August 12, 2026. This dual-language approach aims to reach a broader segment of investors, including those in West Bengal where the company is headquartered.

Accessing the Financial Data

Investors can access the detailed financial statements through digital platforms. The company hosted the PDF containing the unaudited results on its official website. Additionally, the documents were uploaded to the websites of the National Stock Exchange of India Limited (NSE) and BSE Limited. A QR code was also provided in the press release to facilitate quick mobile access to the data.

Document Detail Information
Quarter Ended June 30, 2026
Board Approval Date August 11, 2026
Publication Date August 12, 2026
Newspapers Financial Express, Ekdin
Regulations Cited SEBI LODR Reg 30, Reg 47

Corporate Governance

Pratibha Jaiswal, Company Secretary, certified the compliance submission to the listing departments of both NSE and BSE. Her digital signature and the timestamp confirm the authenticity and timing of the regulatory filing. The registered office of Kanoria Chemicals & Industries Limited remains at KCI Plaza, Kolkata.

What the Numbers Show

The provided source document contains only the procedural announcement of the results and does not include specific financial metrics such as revenue, net profit, or EBITDA. Therefore, no analytical observation regarding performance trends or margin movements can be derived from this text alone. Investors must refer to the linked PDF or stock exchange filings for detailed financial figures.

Historical Stock Returns for Kanoria Chemicals & Industries

1 Day5 Days1 Month6 Months1 Year5 Years
-0.92%-2.64%+8.69%+125.81%+84.51%+1.58%

How are analysts expecting Kanoria Chemicals' Q1 FY26 revenue and net profit figures to compare with the previous quarter and year-on-year trends?

What specific operational or market factors might drive the company's performance in the upcoming Q2 FY26, given the current chemical industry landscape?

Will the Board of Directors recommend a dividend payout for this quarter, and how might that impact shareholder returns?

Kanoria Chemicals & Industries
View Company Insights
View All News
like17
dislike

More News on Kanoria Chemicals & Industries

1 Year Returns:+84.51%